News

The incremental mortality in implantable pacemaker and defibrillator recipients who experience a device infection, compared to patients without device infection, is substantial and persists for at...

New data from 100,438 patients with Boston Scientific implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds...

St. Jude Medical gained CE mark approval of its Ilumien Optis percutaneous coronary intervention (PCI) optimization system to better visualize stent planning and navigation. The system integrates...

Boston Scientific Corporation completed a first-in-human clinical trial utilizing the IntellaTip MiFi XP Ablation Catheter for the treatment of type 1 atrial flutter, an arrhythmia originating in...

St. Jude Medical Inc. has received CE Mark approval of its next-generation Ellipse and SJM Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy...

Endosense, tacticath, contact force, electrophysiology

New study data released at the Heart Rhythm Society (HRS) meeting last week validates the importance of contact force technology focused on improving the efficacy and safety of catheter...

nContact Inc. said it received conditional approval for an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin enrollment in the CONVERGE...

Thermocool Smarttouch, Biosense webster force sensing

Biosense Webster Inc. announced the 12-month safety and effectiveness results of the Thermocool Smarttouch catheter and software module in the treatment of symptomatic, drug refractory, paroxysmal...

Toshiba America Medical Systems Inc. offers electrophysiology (EP) clinicians an Infinix-i cardiovascular X-ray system tailored for EP procedures with a new package of features, accessories and...

Wearable cardioverter defibrillators (WCD) can be an effective therapy option for patients with a transient or undefined arrhythmic risk, according to the WEARIT-II Registry, the largest...

Biotronik announced the U.S. Food and Drug Administration (FDA) granted approval for its Ilesto 7 implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillator (ICD/CRT-D...

BioSense Webster eMARQable Clinical Study nMARQ System Atrial Fibrillation

Biosense Webster Inc. announced the first patient has been enrolled in the reMARQable clinical study. ReMARQable will assess the safety and efficacy of the use of the nMARQ Pulmonary Vein...

GE Healthcare Innova EPVision 2.0, an application that combines information from electrophysiology (EP) recording and live fluoroscopy, and Dose Blueprint, a comprehensive dose management strategy...

The Population Health Research Institute (PHRI) has conducted a further independent analysis of data received from ongoing prospective registries that monitor the performance of the St. Jude...

Boston Scientific has received CE Mark approval for the Rhythmia Mapping System, a 3-D mapping and navigation solution for use in cardiac catheter ablations and other electrophysiology (EP)...

St. Jude Medical Inc., a global medical device company, has announced first enrollment of its MultiPoint Pacing clinical study to build upon its first- to-market Quadripolar Pacing System....

eCardio Diagnostics announced the launch of eCardio Verite — a patient-friendly, wireless monitor offering seamless transition between mobile cardiac telemetry and cardiac event monitoring when...

Zoll WEARIT-II Trial Results Heart Rhythm Society Annual Scientific Session

Zoll Medical said results from the prospective registry and follow-up of Patients Using the Wearable Defibrillator (WEARIT-II) trial will be presented in a late-breaking clinical trial...

St. Jude Medical Inc. announced CE Mark approval and European launch of its Allure Quadra Cardiac Resynchronization Therapy Pacemaker (CRT-P). This CRT-P system offers more pacing...